Results 171 to 180 of about 153,159 (379)
Abstract Purpose Retinopathy of prematurity (ROP) is a major cause of childhood blindness, and selecting the optimal treatment between anti‐vascular endothelial growth factor (anti‐VEGF) and laser therapy is crucial. Understanding their impact on key outcomes, particularly mortality, is essential for informed clinical decision‐making.
Wei‐De Wang+10 more
wiley +1 more source
D. Jabs, R. Nussenblatt, J. Rosenbaum
semanticscholar +1 more source
Fellowships across Europe: Insights from the European Board of Ophthalmology Survey
Abstract Purpose Analyse the results of a European Board of Ophthalmology (EBO) survey on post‐residency training (fellowship) opportunities across Europe, providing insights from ophthalmic educators on the current landscape. Methods A cross‐sectional study was conducted using an anonymous 31‐question online survey distributed to educators in all EBO ...
Rémi Yaïci+22 more
wiley +1 more source
Intra-ocular pressure in Fuchs's heterochromic uveitis. [PDF]
Colby Hart, D M Ward
openalex +1 more source
Abstract Purpose Ophthalmology encompasses comprehensive medical and surgical care for patients with diverse visual system disorders, significantly impacting eye health, vision, and quality of life. European ophthalmologists undergo specialized residency training to acquire necessary competencies, emphasizing theoretical knowledge, clinical and ...
Helena Prior Filipe+70 more
wiley +1 more source
Suprachoroidal and Subretinal Injections of AAV Using Transscleral Microneedles for Retinal Gene Delivery in Nonhuman Primates. [PDF]
Retinal gene therapy using adeno-associated viruses (AAVs) is constrained by the mode of viral vector delivery. Intravitreal AAV injections are impeded by the internal limiting membrane barrier, while subretinal injections require invasive surgery and ...
Chung, Sook Hyun+7 more
core
ABSTRACT Background This study examines the long‐term effectiveness of anti‐VEGF therapy in managing neovascular age‐related macular degeneration (nAMD). Despite the well‐established short‐term improvements of anti‐VEGF therapy, there is limited data on its continued efficacy over extended periods.
Kimberly Spooner+5 more
wiley +1 more source